Drugs - Real World Outcomes is a peer-reviewed english-language open-access journal published by Adis, Springer Healthcare in United Kingdom, operating under an open-access model since 2014. The journal covers Therapeutics. Pharmacology and Pharmacy and materia medica.
Authors are required to pay an article processing charge to publish in Drugs - Real World Outcomes; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY-NC license (see other journals using this license).
Keywords
big data, drug utilization, patient behaviour, real world healthcare
At a glance
- Publisher
- Adis, Springer Healthcare
- Country
- United Kingdom
- Primary language
- English
- License
- CC BY-NC
- Peer review
- Anonymous peer review
- OA since
- 2014
ISSN
- 2199-1154
- electronic
- 2198-9788
Frequently asked questions
Is Drugs - Real World Outcomes peer-reviewed?
Yes — Drugs - Real World Outcomes operates a Anonymous peer review review process.
Does Drugs - Real World Outcomes charge an article processing charge (APC)?
Yes — refer to the journal's APC page for the current rate. A waiver policy is available for eligible authors.
What subjects does Drugs - Real World Outcomes publish?
Drugs - Real World Outcomes publishes research in Therapeutics. Pharmacology and Pharmacy and materia medica.
What languages does Drugs - Real World Outcomes accept?
Drugs - Real World Outcomes accepts manuscripts in English.
What is the ISSN of Drugs - Real World Outcomes?
ISSN:
2199-1154 (print) · 2198-9788 (electronic).How do I submit a manuscript to Drugs - Real World Outcomes?
Submit through the journal's official portal: visit submission page →